Neogen Corporation
Neogen Corporation (NEOG) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Neogen Corporation (NEOG), featuring income statements, balance sheets, and cash flow data.
Neogen Corporation (NEOG) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Neogen Corporation NEOG financial performance.
| Metric | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| Revenue | $220.98M | $231.26M | $216.96M | $236.79M |
| Cost of Revenue | $110.72M | $117.93M | $112.04M | $123.31M |
| Gross Profit | $110.27M | $113.33M | $104.93M | $113.48M |
| Gross Profit Ratio | $0.50 | $0.49 | $0.48 | $0.48 |
| R&D Expenses | $4.47M | $5.11M | $5.20M | $5.14M |
| SG&A Expenses | $100.38M | $104.32M | $97.47M | $95.30M |
| Operating Expenses | $104.85M | $570.81M | $102.67M | $95.91M |
| Total Costs & Expenses | $215.56M | $688.74M | $214.71M | $219.22M |
| Interest Income | $699000.00 | $774000.00 | $993000.00 | $1.10M |
| Interest Expense | $17.74M | $18.14M | $18.61M | $18.62M |
| Depreciation & Amortization | $29.37M | $749000.00 | $29.80M | $28.86M |
| EBITDA | $37.38M | -$457.48M | $32.81M | $41.67M |
| EBITDA Ratio | $0.17 | -$1.98 | $0.15 | $0.18 |
| Operating Income | $5.42M | -$457.48M | $2.26M | $17.57M |
| Operating Income Ratio | $0.02 | -$1.98 | $0.01 | $0.07 |
| Other Income/Expenses (Net) | -$15.14M | -$19.09M | -$17.87M | -$19.44M |
| Income Before Tax | -$9.73M | -$476.57M | -$15.61M | -$6.40M |
| Income Before Tax Ratio | -$0.04 | -$2.06 | -$0.07 | -$0.03 |
| Income Tax Expense | $1.23M | -$20.29M | -$3.00M | -$984000.00 |
| Net Income | -$10.96M | -$456.28M | -$12.61M | -$5.42M |
| Net Income Ratio | -$0.05 | -$1.97 | -$0.06 | -$0.02 |
| EPS | -$0.05 | -$2.10 | -$0.06 | -$0.03 |
| Diluted EPS | -$0.05 | -$2.10 | -$0.06 | -$0.03 |
| Weighted Avg Shares Outstanding | $217.03M | $216.81M | $216.70M | $216.61M |
| Weighted Avg Shares Outstanding (Diluted) | $217.03M | $216.81M | $216.70M | $216.61M |
The company's financials show resilient growth, with revenue advancing from $236.79M in Q4 2024 to $220.98M in Q3 2025. Gross profit remained healthy with margins at 50% in Q3 2025 compared to 48% in Q4 2024. Operating income hit $5.42M last quarter, sustaining a consistent 2% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $37.38M. Net income rose to -$10.96M, while earnings per share reached -$0.05. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan